Parafibromin as a diagnostic instrument for parathyroid carcinoma-lone ranger or part of the posse?

International Journal of Endocrinology

Volumn 2010, Issue , 2010, Pages

  Juhlin, C Christofer ^a   Höög, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; PARAFIBROMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

DIAGNOSTIC VALUE; DISEASE MARKER; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPERPARATHYROIDISM 2 GENE; IMMUNOHISTOCHEMISTRY; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 79952233304     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2010/324964     Document Type: Review

References (33)

1. Shane E., Clinical review 122: parathyroid carcinoma Journal of Clinical En (Pubitemid 32207447)
2. Bondeson L., Sandelin K., Grimelius L., Histopathological variables and DNA cytometry in parathyroid carcinoma American Journal of Surgical Pathology 1993 17 8 820 829 (Pubitemid 23212014)
3. DeLellis R. A., DeLellis R. A., Lloyd R. V., Heitz P. U., Eng C., Parathyroid carcinoma Pathology and Genetics of Tumours of Endocrine Organs 2004 Lyon, France IARC Press 124 127 World Health Organization Classification of Tumours
4. Cryns V. L., Thor A., Xu H. J., Hu S. X., Wierman M. E., Vickery A. L., Benedict W. F., Arnold A., Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma The New England Journal of Medicine 1994 330 11 757 761 (Pubitemid 24080222)
5. Cryns V. L., Rubio M. P., Thor A. D., Louis D. N., Arnold A., p53 Abnormalities in human parathyroid carcinoma Journal of Clinical Endocrinology and Metabolism 1994 78 6 1320 1324
6. Hsi E. D., Zukerberg L. R., Yang W. I., Arnold A., Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study Journal of Clinical Endocrinology and Metabolism 1996 81 5 1736 1739 (Pubitemid 26152455)
7. Farnebo F., Auer G., Farnebo L. O., Teh B. T., Twigg S., Aspenblad U., Thompson N. W., Grimelius L., Larsson C., Sandelin K., Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease World Journal of Surgery 1999 23 1 68 74 (Pubitemid 28565562)
8. Kayath M. J., Martin L. C., Vieira J. G. H., Roman L. M., Nos-Alberti V., A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas European Journal of Endocrinology 1998 139 1 78 83 (Pubitemid 28351239)
9. Vasef M. A., Brynes R. K., Sturm M., Bromley C., Robinson R. A., Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study Modern Pathology 1999 12 4 412 416 (Pubitemid 29203331)
10. Lloyd R. V., Carney J. A., Ferreiro J. A., Jin L., Thompson G. B., van Heerden J. A., Grant C. S., Wollan P. C., Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas Endocrine Pathology 1995 6 4 279 287
11. Carpten J. D., Robbins C. M., Villablanca A., Forsberg L., Presciuttini S., Bailey-Wilsons J., Simonds W. F., Gillanders E. M., Kennedy A. M., Chen J. D., Agarwal S. K., Sood R., Jones M. P., Moses T. Y., Haven C., Petillo D., Leotlela P. D., Harding B., Cameron D., Pannett A. A., Hg A., Heath H., James-Newton L. A., Robinson B., Zarbo R. J., Cavaco B. M., Wassif W., Perrier N. D., Rosen I. B., Kristoffersson U., Turnpenny P. D., Farnebo L. O., Besser G. M., Jackson C. E., Morreau H., Trent J. M., Thakker R. V., Marx S. J., Teh B. T., Larsson C., Hobbs M. R., HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome Nature Genetics 2002 32 4 676 680 (Pubitemid 35435184)
12. Howell V. M., Haven C. J., Kahnoski K., Khoo S. K., Petillo D., Chen J., Fleuren G. J., Robinson B. G., Delbridge L. W., Philips J., Nelson A. E., Krause U., Hammje K., Dralle H., Hoang-Vu C., Gimm O., Marsh D. J., Morreau H., Teh B. T., HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours Journal of Medical Genetics 2003 40 9 657 663 (Pubitemid 37100697)
13. Shattuck T. M., Vlimki S., Obara T., Gaz R. D., Clark O. H., Shoback D., Wierman M. E., Tojo K., Robbins C. M., Carpten J. D., Farnebo L. O., Larsson C., Arnold A., Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma The New England Journal of Medicine 2003 349 18 1722 1729 (Pubitemid 37315009)
14. Rozenblatt-Rosen O., Hughes C. M., Nannepaga S. J., Shanmugam K. S., Copeland T. D., Guszczynski T., Resau J. H., Meyerson M., The parafibromin tumor suppressor protein is part of a human Paf1 complex Molecular and Cellular Biology 2005 25 2 612 620 (Pubitemid 40096583)
15. Chaudhary K., Deb S., Moniaux N., Ponnusamy M. P., Batra S. K., Human RNA polymerase II-associated factor complex: dysregulation in cancer Oncogene 2007 26 54 7499 7507 (Pubitemid 350207717)
16. Lin L., Czapiga M., Nini L., Zhang J. H., Simonds W. F., Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function Molecular Cancer Research 2007 5 2 183 193 (Pubitemid 46423999)
17. Zhang C., Kong D., Tan M. H., Pappas D. L., Wang P. F., Chen J., Farber L., Zhang N., Koo H. M., Weinreich M., Williams B. O., Teh B. T., Parafibromin inhibits cancer cell growth and causes G1 phase arrest Biochemical and Biophysical Research Communications 2006 350 1 17 24 (Pubitemid 44466569)
18. Mosimann C., Hausmann G., Basler K., Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo Cell 2006 125 2 327 341 (Pubitemid 44313810)
19. Wang P., Bowl M. R., Bender S., Peng J., Farber L., Chen J., Ali A., Zhang Z., Alberts A. S., Thakker R. V., Shilatifard A., Williams B. O., Bin T. T., Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice Molecular and Cellular Biology 2008 28 9 2930 2940 (Pubitemid 351556526)
20. Tan M. H., Morrison C., Wang P., Yang X., Haven C. J., Zhang C., Zhao P., Tretiakova M. S., Korpi-Hyovalti E., Burgess J. M., Khee C. S., Cheah W. K., Cao B., Resau J., Morreau H., Bin T. T., Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma Clinical Cancer Research 2004 10 19 6629 6637 (Pubitemid 39346560)
21. Gill A. J., Clarkson A., Gimm O., Keil J., Dralle H., Howell V. M., Marsh D. J., Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias American Journal of Surgical Pathology 2006 30 9 1140 1149 (Pubitemid 44299347)
22. Juhlin C. C., Villablanca A., Sandelin K., Haglund F., Nordenstrm J., Forsberg L., Brnstrm R., Obara T., Arnold A., Larsson C., Hg A., Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification Endocrine-Related Cancer 2007 14 2 501 512 (Pubitemid 47242648)
23. Cetani F., Ambrogini E., Viacava P., Pardi E., Fanelli G., Naccarato A. G., Borsari S., Lemmi M., Berti P., Miccoli P., Pinchera A., Marcocci C., Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? European Journal of Endocrinology 2007 156 5 547 554 (Pubitemid 46796521)
24. Tominaga Y., Tsuzuki T., Matsuoka S., Uno N., Sato T., Shimabukuro S., Goto N., Nagasaka T., Uchida K., Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease World Journal of Surgery 2008 32 5 815 821
25. Fernandez-Ranvier G. G., Khanafshar E., Tacha D., Wong M., Kebebew E., Duh Q. Y., Clark O. H., Defining a molecular phenotype for benign and malignant parathyroid tumors Cancer 2009 115 2 334 344
26. Juhlin C., Larsson C., Yakoleva T., Leibiger I., Leibiger B., Alimov A., Weber G., Hg A., Villablanca A., Loss of parafibromin expression in a subset of parathyroid adenomas Endocrine-Related Cancer 2006 13 2 509 523 (Pubitemid 43886673)
27. Cetani F., Pardi E., Borsari S., Viacava P., Dipollina G., Cianferotti L., Ambrogini E., Gazzerro E., Colussi G., Berti P., Miccoli P., Pinchera A., Marcocci C., Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors Journal of Clinical Endocrinology and Metabolism 2004 89 11 5583 5591 (Pubitemid 39518444)
28. Newey P. J., Bowl M. R., Cranston T., Thakker R. V., Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors Human Mutation 2010 31 3 295 307
29. Howell V. M., Gill A., Clarkson A., Nelson A. E., Dunne R., Delbridge L. W., Robinson B. G., Teh B. T., Gimm O., Marsh D. J., Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma Journal of Clinical Endocrinology and Metabolism 2009 94 2 434 441
30. Juhlin C. C., Haglund F., Villablanca A., Forsberg L., Sandelin K., Brnstrm R., Larsson C., Hg A., Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3- in parathyroid carcinomas International Journal of Oncology 2009 34 2 481 492
31. Juhlin C. C., Nilsson I.-L., Johansson K., Haglund F., Villablanca A., Hg A., Larsson C., Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas Endocrine Pathology 2010 21 3 166 177
32. Bergero N., De Pompa R., Sacerdote C., Gasparri G., Volante M., Bussolati G., Papotti M., Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases Human Pathology 2005 36 8 908 914 (Pubitemid 41187910)
33. Osawa N., Onoda N., Kawajiri H., Tezuka K., Takashima T., Ishikawa T., Miyauchi A., Hirokawa M., Wakasa K., Hirakawa K., Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT International Journal of Molecular Medicine 2009 24 6 733 741